Natriuretic Peptides in Heart Failure and Acute Coronary Syndrome

被引：36
|
作者：
Gaggin, Hanna K. [1 ]
Januzzi, James L., Jr. [1 ]
机构：
[1] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
来源：
CLINICS IN LABORATORY MEDICINE | 2014年 / 34卷 / 01期
关键词：
Laboratory medicine; Cardiac markers; Biomarkers; BNP; NT-proBNP; Heart failure; Acute coronary syndrome; Natriuretic peptides; ACUTE MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT PATIENTS; INCREASED PLASMA-LEVELS; ST-SEGMENT ELEVATION; ACUTE DYSPNEA; CHEST-PAIN; VAL-HEFT; SYSTOLIC DYSFUNCTION; RISK STRATIFICATION; VASOACTIVE PEPTIDES;
D O I：
10.1016/j.cll.2013.11.007
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are the gold standard biomarkers in determining heart failure (HF) diagnosis and prognosis. These natriuretic peptides may also be useful in guiding HF management, but further studies are needed before they can be routinely recommended for that purpose. A novel natriuretic peptide biomarker, mid-regional pro atrial natriuretic peptide (MR-proANP), shows promise in determining diagnosis and prognosis in HF patients. BNP and NT-proBNP may be of use in excluding myocardial infarction and to assist in determining prognosis in acute coronary syndrome (ACS). Therapeutic implication of natriuretic peptides in ACS is unclear.
引用
收藏
页码：43 / +
页数：17
相关论文
共 50 条
  • [41] Natriuretic peptides in therapy for decompensated heart failure
    Natig Gassanov
    Esther Biesenbach
    Evren Caglayan
    Amir Nia
    Uwe Fuhr
    Fikret Er
    [J]. European Journal of Clinical Pharmacology, 2012, 68 : 223 - 230
  • [42] Biomarkers in heart failure: a focus on natriuretic peptides
    Eltayeb, Mohamed
    Squire, Iain
    Sze, Shirley
    [J]. HEART, 2024, 110 (11) : 809 - 818
  • [43] Assessment of heart failure with plasma natriuretic peptides
    Penney, MD
    Hampton, D
    [J]. LANCET, 1998, 351 (9100): : 444 - 444
  • [44] Natriuretic peptides in therapy for decompensated heart failure
    Gassanov, Natig
    Biesenbach, Esther
    Caglayan, Evren
    Nia, Amir
    Fuhr, Uwe
    Er, Fikret
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (03) : 223 - 230
  • [45] Natriuretic peptides in the pathophysiology of congestive heart failure
    Chen H.H.
    Burnett Jr. J.C.
    [J]. Current Cardiology Reports, 2000, 2 (3) : 198 - 205
  • [46] Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome
    Harrington, Josephine
    Jones, W. Schuyler
    Udell, Jacob A.
    Hannan, Karen
    Bhatt, Deepak L.
    Anker, Stefan D.
    Petrie, Mark C.
    Vedin, Ola
    Butler, Javed
    Hernandez, Adrian F.
    [J]. JACC-HEART FAILURE, 2022, 10 (06) : 404 - 414
  • [47] Insights into natriuretic peptides in heart failure: An update
    Korinek J.
    Boerrigter G.
    Mohammed S.F.
    Burnett J.C.
    [J]. Current Heart Failure Reports, 2008, 5 (2) : 97 - 104
  • [48] CARDIAC NATRIURETIC PEPTIDES IN HEART-FAILURE
    NICHOLLS, MG
    RICHARDS, AM
    CROZIER, IG
    ESPINER, EA
    IKRAM, H
    [J]. ANNALS OF MEDICINE, 1993, 25 (06) : 503 - 505
  • [49] Deadly combination: acute heart failure and acute coronary syndrome
    De Campos, D. Diana
    Saleiro, C.
    Lopes, J. M.
    Gomes, A. R. M.
    Puga, L.
    Sousa, J. P.
    Ribeiro, J. M.
    Botelho, A.
    Quefi, S.
    Fernandes, D.
    Teixeira, R.
    Goncalves, L.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 299 - 299
  • [50] Comparison of troponin and natriuretic peptides in Takotsubo syndrome and acute coronary syndrome: a meta-analysis
    Couch, Liam Steven
    Garrard, James W.
    Henry, John A.
    Kotronias, Rafail A.
    Alaour, Bashir
    De Maria, Giovanni Luigi
    Channon, Keith M.
    Banning, Adrian P.
    Lyon, Alexander Richard
    Marber, Michael
    Kaier, Thomas Edward
    [J]. OPEN HEART, 2024, 11 (01):
12345